Jean-Frederic Viret Insider Trading $CHRS Coherus BioSciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jean-Frederic Viret.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jean-Frederic Viret. Jean-Frederic Viret is VP and Chief Financial Officer in ANESIVA, INC. ($CGTK) and Chief Financial Officer in Coherus BioSciences, Inc. ($CHRS).
Jean-Frederic Viret in Coherus BioSciences, Inc.
Trading Symbol: CHRSIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jean-Frederic Viret: Chief Financial Officer
Holdings: 68,697 shares
Current Value: $1,830,775
Latest Transaction: Feb 03 2021
$CHRS Market Capitalization: $1.03B
$CHRS Previous Close: $26.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jean-Frederic Viret in Coherus BioSciences, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 03 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 7,402 | 74,390 | 54,167 | |
Feb 03 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 21.55 | 7,402 | 159,513 | 61,295 | 68.7 K to 61.3 K (-10.77 %) |
Feb 03 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 7,402 | 74,390 | 68,697 | 61.3 K to 68.7 K (+12.08 %) |
Jan 27 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 40,000 | 402,000 | 61,569 | |
Jan 27 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.00 | 6,144 | 116,736 | 61,295 | 67.4 K to 61.3 K (-9.11 %) |
Jan 27 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.10 | 40,000 | 804,000 | 67,439 | 107.4 K to 67.4 K (-37.23 %) |
Jan 27 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 40,000 | 402,000 | 107,439 | 67.4 K to 107.4 K (+59.31 %) |
Jan 13 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 17.58 | 62,500 | 1,098,750 | 62,500 | |
Jan 13 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Grant | A | 0.00 | 31,250 | 0 | 67,439 | 36.2 K to 67.4 K (+86.35 %) |
Jan 12 2021 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Payment of Exercise | F | 18.18 | 4,080 | 74,174 | 36,189 | 40.3 K to 36.2 K (-10.13 %) |
Nov 19 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 1,500 | 20,250 | 110,241 | |
Nov 19 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 1,500 | 20,250 | 40,269 | 38.8 K to 40.3 K (+3.87 %) |
Nov 19 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 17.49 | 1,995 | 34,896 | 38,769 | 40.8 K to 38.8 K (-4.89 %) |
Feb 21 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 3,159 | 31,748 | 101,569 | |
Feb 21 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 22.33 | 3,159 | 70,552 | 46,841 | 50 K to 46.8 K (-6.32 %) |
Feb 21 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 3,159 | 31,748 | 50,000 | 46.8 K to 50 K (+6.74 %) |
Jan 17 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 6,318 | 63,496 | 104,728 | |
Jan 17 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.08 | 2,798 | 56,186 | 46,841 | 49.6 K to 46.8 K (-5.64 %) |
Jan 17 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.67 | 3,520 | 69,238 | 49,639 | 53.2 K to 49.6 K (-6.62 %) |
Jan 17 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 6,318 | 63,496 | 53,159 | 46.8 K to 53.2 K (+13.49 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 17.73 | 62,500 | 1,108,125 | 62,500 | |
Jan 14 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Grant | A | 0.00 | 31,250 | 0 | 46,841 | 15.6 K to 46.8 K (+200.44 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Payment of Exercise | F | 17.73 | 7,077 | 125,475 | 15,591 | 22.7 K to 15.6 K (-31.22 %) |
Jan 14 2020 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Grant | A | 0.00 | 19,365 | 0 | 22,668 | 3.3 K to 22.7 K (+586.29 %) |
Nov 22 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 3,159 | 31,748 | 111,046 | |
Nov 22 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.59 | 3,159 | 61,872 | 3,303 | 6.5 K to 3.3 K (-48.89 %) |
Nov 22 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 3,159 | 31,748 | 6,462 | 3.3 K to 6.5 K (+95.64 %) |
Nov 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 18.88 | 3,112 | 58,757 | 3,303 | 6.4 K to 3.3 K (-48.51 %) |
Oct 22 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.02 | 1,388 | 26,400 | 6,385 | 7.8 K to 6.4 K (-17.86 %) |
Oct 18 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 3,159 | 31,748 | 114,205 | |
Oct 18 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.00 | 3,159 | 60,021 | 7,773 | 10.9 K to 7.8 K (-28.90 %) |
Oct 18 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 3,159 | 31,748 | 10,932 | 7.8 K to 10.9 K (+40.64 %) |
Sep 25 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 21.78 | 740 | 16,117 | 7,773 | 8.5 K to 7.8 K (-8.69 %) |
Sep 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 3,159 | 31,748 | 117,364 | |
Sep 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.44 | 3,159 | 64,560 | 8,513 | 11.7 K to 8.5 K (-27.06 %) |
Sep 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 3,159 | 31,748 | 11,672 | 8.5 K to 11.7 K (+37.11 %) |
Aug 23 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 6,318 | 63,496 | 120,523 | |
Aug 23 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 21.75 | 6,058 | 131,766 | 8,513 | 14.6 K to 8.5 K (-41.58 %) |
Aug 23 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.73 | 260 | 5,389 | 14,571 | 14.8 K to 14.6 K (-1.75 %) |
Aug 23 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 6,318 | 63,496 | 14,831 | 8.5 K to 14.8 K (+74.22 %) |
Aug 21 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.04 | 3,000 | 57,120 | 8,513 | 11.5 K to 8.5 K (-26.06 %) |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 10.05 | 3,159 | 31,748 | 126,841 | |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.81 | 100 | 2,081 | 11,513 | 11.6 K to 11.5 K (-0.86 %) |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.32 | 3,059 | 62,166 | 11,613 | 14.7 K to 11.6 K (-20.85 %) |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 10.05 | 3,159 | 31,748 | 14,672 | 11.5 K to 14.7 K (+27.44 %) |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 20.00 | 667 | 13,340 | 11,513 | 12.2 K to 11.5 K (-5.48 %) |
Jun 20 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 19.31 | 3,000 | 57,926 | 12,180 | 15.2 K to 12.2 K (-19.76 %) |
Mar 22 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 14.92 | 3,000 | 44,762 | 13,185 | 16.2 K to 13.2 K (-18.54 %) |
Jan 15 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 12.37 | 126,000 | 1,558,620 | 126,000 | |
Jan 15 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Payment of Exercise | F | 12.37 | 6,297 | 77,894 | 16,185 | 22.5 K to 16.2 K (-28.01 %) |
Jan 15 2019 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Grant | A | 0.00 | 16,685 | 0 | 22,482 | 5.8 K to 22.5 K (+287.82 %) |
Sep 25 2018 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 740 | 9,990 | 111,741 | |
Sep 25 2018 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 740 | 9,990 | 4,519 | 3.8 K to 4.5 K (+19.58 %) |
Jul 25 2018 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 18.56 | 9,291 | 172,472 | 3,779 | 13.1 K to 3.8 K (-71.09 %) |
Feb 05 2018 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 10.05 | 130,000 | 1,306,500 | 130,000 | |
Dec 19 2017 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Grant | A | 0.00 | 6,966 | 0 | 9,958 | 3 K to 10 K (+232.82 %) |
Aug 08 2017 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 12.70 | 67,000 | 850,900 | 67,000 | |
Jan 27 2017 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 3,900 | 52,650 | 112,481 | |
Jan 27 2017 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 27.00 | 3,900 | 105,300 | 2,992 | 6.9 K to 3 K (-56.59 %) |
Jan 27 2017 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 3,900 | 52,650 | 6,892 | 3 K to 6.9 K (+130.35 %) |
Dec 20 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 667 | 9,005 | 116,381 | |
Dec 20 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 3,900 | 52,650 | 117,048 | |
Dec 20 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 667 | 9,005 | 2,992 | 2.3 K to 3 K (+28.69 %) |
Dec 20 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 28.30 | 3,900 | 110,365 | 2,325 | 6.2 K to 2.3 K (-62.65 %) |
Dec 20 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 3,900 | 52,650 | 6,225 | 2.3 K to 6.2 K (+167.74 %) |
Nov 22 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 3,900 | 52,650 | 120,948 | |
Nov 22 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 28.19 | 3,900 | 109,955 | 2,325 | 6.2 K to 2.3 K (-62.65 %) |
Nov 22 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 3,900 | 52,650 | 6,225 | 2.3 K to 6.2 K (+167.74 %) |
Oct 25 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 3,900 | 52,650 | 124,848 | |
Oct 25 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 30.62 | 3,900 | 119,403 | 2,325 | 6.2 K to 2.3 K (-62.65 %) |
Oct 25 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 3,900 | 52,650 | 6,225 | 2.3 K to 6.2 K (+167.74 %) |
Sep 28 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 3,900 | 52,650 | 128,748 | |
Sep 28 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Sell | S | 29.88 | 3,900 | 116,550 | 2,325 | 6.2 K to 2.3 K (-62.65 %) |
Sep 28 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 3,900 | 52,650 | 6,225 | 2.3 K to 6.2 K (+167.74 %) |
Jul 08 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 1,925 | 25,988 | 132,648 | |
Jul 08 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 1,925 | 25,988 | 2,325 | 400 to 2.3 K (+481.25 %) |
May 13 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 17.17 | 78,472 | 1,347,364 | 78,472 | |
Mar 30 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | M | 13.50 | 400 | 5,400 | 134,573 | |
Mar 30 2016 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Buy | M | 13.50 | 400 | 5,400 | 400 | 0 to 400 |
Apr 03 2015 | CHRS | Coherus BioScience ... | Viret Jean-Frederic | Chief Financial Off ... | Option Exercise | A | 29.00 | 100,000 | 2,900,000 | 100,000 |
Page: 1